Allied Market Research
image  Direct : +1 (617) 674-4143 | Toll Free : +1 (855) 711-1555


Report Image
Global Cardiac Biomarkers Market (Types, Application and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2012 - 2020
Upcoming: Dec-2014    |    Formats: PDF & Excel    |    Code: DI 14309    |   
  • Report
    Overview
  • Table of
    Contents
  • Research
    Methodology

Cardiac Biomarkers are protein substances released into the blood stream from damaged heart muscles. These are the biological parameters that are used to detect the presence of cardiovascular diseases. According to World Health Organization, in 2008, 17.3 million people died due to cardiovascular diseases and it is expected to reach 23.3 million by 2030. This increase in cardiovascular diseases across the globe widens the global cardiac biomarkers market. With the prevalence of these cardiovascular diseases, demand for cardiac biomarkers would increase in future for early diagnosis and disease management. The study will help to identify the opportunities for global players in the cardiac biomarkers market to generate maximum profit.

The major drivers for growth of cardiac biomarkers are increase in number of cardiovascular diseases, ageing population and precision of cardiac biomarkers in early detection of risks associated with cardiovascular diseases. The restraints for cardiac biomarkers market are side effects related to biomarkers such as skeletal muscle injury and their less specific actions in detecting the presence of cardiovascular diseases.

Cardiac biomarkers Type Market analysis

Cardiac biomarker type market is segmented in enzymatic and non enzymatic cardiac biomarkers. Enzymatic cardiac biomarker includes myocardial muscle creatine kinase CK (MB), Lactate dehydrogenase (LDH 1), Aspartate Transaminase (AST), Myleperoxidase, Matrix metalloproteinase and Non enzymatic cardiac biomarker includes Troponins(T,I),Myoglobin, Pro-brain natriuretic peptide, and Ischemia modifies albumin. Tropoin T and I are preferred mostly for the diagnosis of myocardial infarction due to its highest sensitivities and specificities.

Cardiac biomarkers Application Market analysis

Cardiac biomarkers application market analysis is segmented into myocardial infarction, congestive heart failure, acute coronary syndrome, atherosclerosis and others. Myocardial infarction is the leading cause of mortality in developed countries.

Cardiac biomarkers Geographic Market analysis

Geographically, the market is segmented into North America, Europe, Asia Pacific and rest of the world. The global cardiac biomarker market is dominated by North America and Europe due to increasing patient population suffering from cardiovascular diseases, lack of physical activities and unhealthy diet. India, South East Asia and china are the emerging markets for cardiac biomarkers due to increase in incidence of coronary artery diseases.

Competitive landscape

Key players of cardiac biomarker market are Ortho-clinical diagnostics, Abbott laboratories, Roche Diagnostics Corporation, Medtronic, Inc. Biosensors International Ltd. and others. The strategies adopted by these players are Product launch, merger and acquisition and research development collaborations. Product launch strategy is adopted by most of the players. Roche Diagnostics introduces Cobas-H232 Handheld cardiac Marker system II-38, a cardiac biomarker used for the diagnosis of cardiovascular diseases.

High level analysis

Cardiac biomarkers market is analyzed through Porter’s five forces model, which explains that bargaining power of supplier varies with application of cardiac biomarkers and bargaining power of buyers is less as cost of switching is high .Threat of new entrant is less as high capital investment is require for new start-up. SWOT analysis provides a way for making strategic business decisions. The business strategies adopted by the key players are analyzed. The impact of drivers for growth, restraints and opportunities for cardiac biomarkers market is described in detail.

Key Benefits

  • In depth analysis of cardiac biomarker market, which is segmented on the basis of type, application and geography provides clear understanding of the market.
  • Quantitative analysis of the current market and estimations through 2013-2020. Thus helping cardiac biomarker marketers to analyze the market.
  • Assessment and ranking of the factors affecting the global market and their impact on the cardiac biomarker market.
  • Study on the bargaining power of buyers and suppliers in the market, based on porter’s five force analysis. Thus helping cardiac biomarker manufacturer to analyze the market.
  • SWOT and competitive analysis of the key players, which would help stakeholders to understand trends followed by their competitors and take actionable decisions.

Key Deliverables

The global cardiac biomarker market is segmented based on type, application, and geography.

Market by Type

  • Enzymatic 
  • Myocardial Muscle Creatine Kinase (CK(MB))
  • Lactate Dehydrogenase (LDH 1)
  • Aspartate Transaminase (AST)
  • Myleperoxidase
  • Matrix Metalloproteinase
  • Non Enzymatic 
  • Troponins(T,I)
  • Myoglobin
  • Pro-brain Natriuretic Peptide
  • Ischemia modifies albumin
  • Troponins (T,I)
  • Myoglobin
  • Pro-Brain Natriuretic Peptide
  • Ischemia Modified Albumin

Market by Application 

  • Myocardial Infarction
  • Congestive Heart Failure
  • Acute Coronary Syndrome
  • Atherosclerosis
  • Others 

Market by Geography

  • North America
  • Europe 
  • Asia Pacific
  • Rest of the world
Please fill in the form below to get a TOC

* Marked Fields are Mandatory






image



Can't read the image? click here to refresh

     
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.
SIMILAR MARKET STUDIES

Published Reports

Regenerative medicines have the unique ability to repair, replace and regenerate tissues and organs, affected due to some injury, disease or due to natural aging process. These medicines are capable of restoring the functionality of cells and tissues. These medicines find applicability in wide range of degenerative disorders including dermatology, neurodegenerative diseases, cardiovascular and orthopedic applications. Researchers are engaged in developing technologies based on biologics, genes, somatic as well as stem cells.
30 Jun 2014 | Price: $4515(SU) | View Details >>

DNA diagnostics is a cutting edge method which is set to revolutionize the field of medical diagnostics. This technique enables medical professionals to identify various diseases, such as cancer, infectious diseases, and myogenic disorders, and to determine the appropriate treatment for the same. It is also used for clinical diagnostic confirmation and in prenatal diagnostics.
27 Aug 2014 | Price: $4515(SU) | View Details >>

Synthetic biology is a novel field that finds its origin at the intersection of biology and engineering. It involves designing and construction of biological systems or devices that can be applied in varied domains to get specified results. Its a multidisciplinary effort made by scientists to understand the functioning of biological organisms, cells & genes and implementation of artificial genetic processes to give specific characteristics to an organism. It can even be used to develop a completely new biological system. Global synthetic biology market was valued at $3.0 billion in 2013 and it is estimated to reach $38.7 billion by 2020, growing at a CAGR of 44.2% during the forecast period.
27 May 2014 | Price: $4515(SU) | View Details >>

The bioinformatics market is expected to grow to $12.86 billion by 2020 with a CAGR of 21.2% during 2014-2020. Bioinformatics is an interdisciplinary field that is used in the development and storage of data, thus helping in the analysis, organization and retrieval of the biological data. Bioinformatics has various applications and thus forms part of almost all the fields in biology. Bioinformatics form a part of agriculture, animal breeding, molecular medicine, preventive medicine, etc. The major factors driving the bioinformatics market is the need for integrated data, rising demand for drug development and discovery, the increasing focus in genomics & proteomics and the favorable government initiatives.
28 May 2014 | Price: $4515(SU) | View Details >>

Companion diagnostics are in-vitro diagnostics that provide information about therapeutic responses of patients for a specific treatment. Companion diagnostics market is still nascent, and it is projected to reach $3.5 billion by 2020 from a base value of $1.1 billion in 2013, growing at a CAGR of 20% during 2014 to 2020. The global companion diagnostic market is segmented based on indication, technology and geography (North America, Europe, Asia Pacific and LAMEA). Geographically, LAMEA is the fastest growing region. The key drivers for this market are the increase in the discovery of biomarkers and co-development of drug and corresponding diagnostic. However, cost associated with developing drugs could impede the growth of this market.
10 Jun 2014 | Price: $4515(SU) | View Details >>

Upcoming Reports

Veterinary diagnostics are noninvasive methods used to identify and examine the causes of diseases in animals. Various new technologies from human diagnostics segments are being adapted for the veterinary domain. This trend is expected to continue in the future, thereby contributing to the growth of this market.
Price: $4515 | Pre Book Price: $3950 | View Details >>

The label free detection method is used for detecting biomolecules and their interactions. This method has emerged as an attractive research and development tool in the pharmaceutical and biotech industry.
Price: $4515 | Pre Book Price: $3950 | View Details >>

DNA sequencing is a process used to determine the order of nucleotides within DNA molecules. Prenatal DNA sequencing is the method of sequencing the DNA isolated from pregnant women’s blood to reveal the full genetic code of a fetus. Prenatal DNA sequencing is used to sequence the whole genome of unborn baby that effectively detects the diseases
Price: $4515 | Pre Book Price: $3950 | View Details >>

Identification documents and PIN are traditional methods used to verify the identity of a human being. However, an increasing number of cases of security threats, illegal transactions at ATMs, unauthorised immigration and unauthorised infiltration across borders are factors which have resulted in the evolution of new generation biometrics methods. New generation biometrics refers to technologies that are used to verify the identity of individuals through biological characteristics such as facial expression, voice, palm, fingerprints, signature, iris, vein and DNA.
Price: $4515 | Pre Book Price: $3950 | View Details >>

Tissue engineering is the combination of biology medicine and engineering to create products that would improve or replace biological functions or organs. More than a decade ago, the industry introduced the first FDA approved tissue-engineering product, which was a skin substitute product. These products provide natural regeneration of tissues or cells, and hence are highly effective. The medical biotechnology industry was estimated to be $160 billion in 2012.The major drivers in this industry are chronic wound and orthopedic application segment.
Price: $4515 | Pre Book Price: $3950 | View Details >>
First time Buyer ?
Check offer and
discount on this report


Request Quote



Pre Book Price
Original Price
$3950
$4515


WHY ALLIED MARKET RESEARCH?
INFALLIBLE METHODOLOGY
To ensure high level data integrity, accurate analysis and impeccable forecasts
ANALYST SUPPORT
For complete satisfaction
CUSTOMIZATION
On-demand customization of scope of the report to exactly meet your needs
TARGETED MARKET
Targeted market view to eliminate redundant information to provide valued information and save time of the reader






Top